These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34746853)

  • 1. Optimized protocol to create deletion in adherent cell lines using CRISPR/Cas9 system.
    Farooq U; Notani D
    STAR Protoc; 2021 Dec; 2(4):100857. PubMed ID: 34746853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimized CRISPR/Cas9-mediated single nucleotide mutation in adherent cancer cell lines.
    Gao P; Dong X; Wang Y; Wei GH
    STAR Protoc; 2021 Jun; 2(2):100419. PubMed ID: 33870225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protocol for establishing knockout cell clones by deletion of a large gene fragment using CRISPR-Cas9 with multiple guide RNAs.
    Saito AC; Higashi T; Chiba H
    STAR Protoc; 2024 Sep; 5(3):103179. PubMed ID: 38972040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimized protocol for gene editing in adipocytes using CRISPR-Cas9 technology.
    Qiu Y; Ding Q
    STAR Protoc; 2021 Mar; 2(1):100307. PubMed ID: 33554142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protocol for editing fibroblasts with in vitro transcribed Cas9 mRNA and profile off-target editing by optimized GUIDE-seq.
    Li Z; Reint G; Haapaniemi EM
    STAR Protoc; 2023 Dec; 4(4):102662. PubMed ID: 37889758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR-Cas9 Ribonucleoprotein-Mediated Genomic Editing in Primary Innate Immune Cells.
    Hildreth AD; Riggan L; O'Sullivan TE
    STAR Protoc; 2020 Dec; 1(3):100113. PubMed ID: 33377009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimized protocols for efficient gene editing in mouse hepatocytes
    Chen Y; Ding Q
    STAR Protoc; 2022 Mar; 3(1):101062. PubMed ID: 35005644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protocol for the saturation and multiplexing of genetic variants using CRISPR-Cas9.
    Sahu S; Sullivan T; Southon E; Caylor D; Geh J; Sharan SK
    STAR Protoc; 2023 Dec; 4(4):102702. PubMed ID: 37948185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A user-friendly and streamlined protocol for CRISPR/Cas9 genome editing in budding yeast.
    Novarina D; Koutsoumpa A; Milias-Argeitis A
    STAR Protoc; 2022 Jun; 3(2):101358. PubMed ID: 35712010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical-genetic CRISPR-Cas9 screens in human cells using a pathway-specific library.
    Hundley FV; Toczyski DP
    STAR Protoc; 2021 Sep; 2(3):100685. PubMed ID: 34382013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR-Cas9-mediated induction of large chromosomal inversions in human bronchial epithelial cells.
    Angelopoulou A; Papaspyropoulos A; Papantonis A; Gorgoulis VG
    STAR Protoc; 2022 Jun; 3(2):101257. PubMed ID: 35330963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generating mutant
    Li HH; Li JC; Su MP; Liu KL; Chen CH
    STAR Protoc; 2021 Jun; 2(2):100432. PubMed ID: 33899015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR-Cas9-Based Genome Editing and Cytidine Base Editing in
    Wang Y; Wang Z; Ji Q
    STAR Protoc; 2020 Jun; 1(1):100025. PubMed ID: 33111078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protocol to efficiently induce CRISPR-Kill-mediated cell ablation in Arabidopsis thaliana.
    Gehrke F; Wolf S; Puchta H
    STAR Protoc; 2024 Jun; 5(2):103072. PubMed ID: 38768032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient CRISPR-Cas9-mediated genome editing for characterization of essential genes in
    Picchi-Constante GFA; Hiraiwa PM; Marek M; Rogerio VZ; Guerra-Slompo EP; Romier C; Zanchin NIT
    STAR Protoc; 2022 Jun; 3(2):101324. PubMed ID: 35496799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protocol for efficient CRISPR-Cas9-mediated fluorescent tag knockin in hard-to-transfect erythroid cell lines.
    Deleuze V; Soler E; Andrieu-Soler C
    STAR Protoc; 2024 Jun; 5(2):103016. PubMed ID: 38640065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimized protocol for CRISPR knockout of human iPSC-derived macrophages.
    Navarro-Guerrero E; Baronio R; Tay C; Knight JC; Ebner DV
    STAR Protoc; 2024 Mar; 5(1):102903. PubMed ID: 38401123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiplexed CRISPR-Cas9 protocol for large transgene integration into the Schistosoma mansoni genome.
    Ittiprasert W; Moescheid MM; Mann VH; Brindley PJ
    STAR Protoc; 2024 Mar; 5(1):102886. PubMed ID: 38354082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protocol for CRISPR-Cas9-mediated genome editing to study spermatogenesis in Caenorhabditis elegans.
    Wang P; Cao Z; Wang Q; Ma X; Wang N; Chen L; Zhao Y; Miao L
    STAR Protoc; 2023 Dec; 4(4):102720. PubMed ID: 37967017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repurposing the Native Type I-F CRISPR-Cas System in
    Xu Z; Li Y; Yan A
    STAR Protoc; 2020 Jun; 1(1):100039. PubMed ID: 33111087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.